CXCR1 - chemokine (C-X-C motif) receptor 1 Gene

Also Known as CXCR2; IL8RA; IL8RB

Species: Canis lupus familiaris (sub-species: familiaris)

Gene Type: protein coding
Gene ID: 478906

CXCR1 Products (1)

mRNA Protein Name
XM_038447921.1 XP_038303849.1 C-X-C chemokine receptor type 2

CXCR1 Protein Structure

7tmA_CXCR1_2

7tmA_CXCR1_2: cd15178 (46 - 322)

7tmA_CXCR1_2

7tmA_CXCR1_2: cd15178 (46 - 73)

7tmA_CXCR1_2

7tmA_CXCR1_2: cd15178 (80 - 105)

7tmA_CXCR1_2

7tmA_CXCR1_2: cd15178 (116 - 146)

7tmA_CXCR1_2

7tmA_CXCR1_2: cd15178 (157 - 179)

7tmA_CXCR1_2

7tmA_CXCR1_2: cd15178 (205 - 233)

7tmA_CXCR1_2

7tmA_CXCR1_2: cd15178 (241 - 271)

7tmA_CXCR1_2

7tmA_CXCR1_2: cd15178 (290 - 315)

  • 0
  • 100
  • 200
  • 300
  • 358 a.a.
Protein Preferred Names Protein Names

C-X-C chemokine receptor type 2

  • chemokine (C-X-C motif) receptor 2

  • interleukin 8 receptor, alpha

  • interleukin 8 receptor, beta

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (5)
Cat. No. Product Name Effect
Purity Phase
HY-15251 Reparixin Inhibitor 99.99% Phase 3
HY-15252 Reparixin L-lysine salt Inhibitor 99.87% Phase 3
HY-19519A Ladarixin sodium Antagonist 99.84% Phase 3
HY-10198 Navarixin Antagonist 99.33% Phase 2
HY-119339 SX-682 Inhibitor 99.64% Phase 2

Pre-clinical Phase

Bioactive Molecules (5)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-12927 SX-517 Antagonist 99.90% Unkown
HY-10011 SCH 563705 Antagonist 99.86% Unkown
HY-165428 SCH-900875 Inhibitor 98.16% Unkown
HY-120878 CXCR2-IN-2 Antagonist 99.52% Unkown
HY-114366 BC-1485 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens CXCR1 NCBI NCBI:3577